CurePSP Expands Grant Program with $155,000 Investment in Studying Care for Rare Neurological DiseasesNEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- CurePSP announced the latest recipients of the Collaborative Approaches to Resources, Education and Support (CARES) grants, awarding a total of $155,000 to four projects spanning seven leading medical institutions in the U.S. and Canada.
CurePSP Explains Progressive Supranuclear Palsy After Rev. Jesse L. Jackson’s PassingNEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The passing of Rev. Jesse L. Jackson, Sr. has cast a spotlight on progressive supranuclear palsy (PSP), one of the most misunderstood neurodegenerative diseases affecting Americans today. As tributes pour in, so too have questions about the disease he lived with for over a decade. First diagnosed with Parkinson's in 2017, Rev. Jackson did not receive his PSP diagnosis until 2024 — facing the same confusion and uncertainty that define the diagnostic journey for thousands of PSP families.
